The Journal of Organic Chemistry
Article
129.8, 128.3, 123.3, 35.4, 29.9, 25.7, 17.7; MS (CI+) m/z: [M − H]+
calcd for C12H1435Cl, 193.0779; found, 193.0777.
yloxy)pent-3-en-1-yl)oxirane (10a). Following the general procedure
for relay cross-metathesis using epoxy allyl ether (E)-5a (53 mg) and
alkene 7b (165 mg), with regular addition of 7b at 10 min intervals to
keep the reaction volume constant throughout the whole reaction
process, gave first 10a (14.3 mg, 0.07 mmol, 27%) as a colorless oil
and a mixture of E/Z geometrical isomers [E/Z = 49:51], and second
9a (29.0 mg, 0.09 mmol, 37%) as a colorless oil. 9a: 10.14469/hpc/
6466. Rf 0.30 (10% EtOAc in pentanes); IR (ATR, neat) 3023, 1670
2-Methylnon-2-ene (7h).40 Following the general procedure for
the formation of trisubstituted alkenes using heptanal (1.40 mL, 10.0
mmol, 1.0 equiv) gave alkene 7h (0.59 g, 4.2 mmol, 42%) as a
colorless oil. 10.14469/hpc/5756. Rf 0.94 (pentanes); 1H NMR (400
MHz, CDCl3): δ 5.24−5.01 (m, 1H), 2.03−1.88 (m, 2H), 1.69 (d, J =
1.4 Hz, 3H), 1.60 (s, 3H), 1.36−1.23 (m, 8H), 0.89 (t, J = 6.7 Hz,
3H); 13C{1H} NMR (101 MHz, CDCl3): δ 131.2, 125.1, 32.0, 30.0,
29.2, 28.2, 25.9, 22.8, 17.8, 14.3; HRMS (EI+) m/z: [M]•+ calcd for
C10H20, 140.1560; found, 140.1554.
1
cm−1; H NMR (400 MHz, CDCl3): δ 7.31−7.26 (m, 2H), 7.21−
7.15 (m, 3H), 5.80−5.70 (m, 1H), 5.66−5.56 (m, 1H), 5.42−5.35
(m, 1H), 3.95 (d, J = 6.8, 2H), 3.91 (dd, J = 6.0, 0.9 Hz, 2H), 2.71
(m, 3H), 2.38 (m, 2H), 2.27−2.07 (m, 2H), 1.71−1.62 (m, 5H), 1.30
(s, 3H), 1.26 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 141.9,
139.1, 133.7, 128.4, 128.3, 127.1, 125.8, 121.5, 70.8, 66.3, 64.0, 58.4,
36.2, 35.5, 34.1, 27.2, 24.9, 18.7, 16.5. HRMS (CI+) m/z: [M + H]+
calcd for C21H31O2, 315.2319; found, 315.2323. 10a: 10.14469/hpc/
6469. Rf 0.60 (10% EtOAc in pentanes); IR (ATR, neat) 1662 cm−1;
1H NMR (400 MHz, CDCl3): δ 6.22 (dq, J = 12.5, 1.6 Hz, 0.51H,
(E)-9a), 5.96 (dq, J = 6.3, 1.7 Hz, 0.49H, (Z)-9a), 5.41 (m, 1H), 4.79
(dq, J = 13.3, 6.7 Hz, 0.51H, (E)-9a), 4.38 (appr. qu., J = 6.8 Hz,
0.49H, (Z)-9a), 4.26 (d, J = 6.7 Hz, 1.02H, (E)-9a), 4.18 (d, J = 6.7
Hz, 0.98H, (Z)-9a), 2.70 (t, J = 6.3 Hz, 1H), 2.28−2.07 (m, 2H),
1.73−1.60 (m, 5H), 1.57 (dd, J = 6.8, 1.7 Hz, 1.53H, (E)-9a), 1.55
(dd, J = 6.7, 1.6 Hz, 1.47H, (Z)-9a), 1.30 (s, 3H), 1.26 (d, J = 1.7 Hz,
3H). The E/Z ratio was determined by integration of the resonances
at δ 4.26 (major) and 4.18 (minor) ppm; 13C{1H} NMR (101 MHz,
CDCl3): δ 146.2, 145.1, 139.8, 139.7, 128.5, 121.0, 120.4, 101.2, 98.8,
68.2, 65.7, 64.0, 58.4, 36.2, 36.2, 27.1, 24.9, 18.8, 16.6, 12.7, 9.3.
HRMS (CI+) m/z: [M + H]+ calcd for C13H23O2, 211.1693; found,
211.1694.
4-Ethyl-2-methyloct-2-ene (7i). Following the general procedure
for the formation of trisubstituted alkenes using 2-ethylhexanal (1.56
mL, 10.0 mmol, 1.0 equiv) gave alkene 7i (0.87 g, 5.7 mmol, 57%) as
a colorless oil. 10.14469/hpc/5760. Rf 0.92 (pentanes); 1H NMR
(400 MHz, CDCl3): δ 4.79 (br d, J = 9.8 Hz, 1H), 2.13−2.01 (m,
1H), 1.71 (d, J = 1.4 Hz, 3H), 1.60 (d, J = 1.3 Hz, 3H), 1.45−1.06
(m, 8H), 0.87 (t, J = 7.1 Hz, 3H), 0.81 (t, J = 7.4 Hz, 3H); 13C{1H}
NMR (101 MHz, CDCl3): δ 130.8, 130.4, 39.8, 35.8, 29.8, 29.0, 26.0,
23.1, 18.4, 14.3, 11.9; HRMS (EI+) m/z: [M]•+ calcd for C11H22,
154.1721; found, 154.1716.
(2-Methylprop-1-en-1-yl)benzene (7j).20 Following the general
procedure for the formation of trisubstituted alkenes using
benzaldehyde (1.02 mL, 10.0 mmol, 1.0 equiv) gave alkene 7j (1.30
g, 9.8 mmol, 98%) as a colorless oil. 10.14469/hpc/5757. Rf 0.58
1
(pentanes); IR (ATR, neat) 3021, 1657 cm−1; H NMR (400 MHz,
CDCl3): δ 7.37−7.28 (m, 2H), 7.28−7.15 (m, 3H), 6.29 (s, 1H), 1.93
(s, 3H), 1.88 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 138.9,
135.6, 128.9, 128.2, 125.9, 125.3, 27.0, 19.6; HRMS (EI+) m/z: [M]•+
calcd for C10H12, 132.0934; found, 132.0933.
(3-Methylbut-2-en-1-yl)benzene (7k).41 Following the general
procedure for the formation of trisubstituted alkenes using phenyl-
acetaldehyde (1.17 mL, 10.0 mmol, 1.0 equiv) gave alkene 7k (0.40 g,
2.8 mmol, 28%) as a colorless oil. 10.14469/hpc/5758. Rf 0.63
(pentanes); IR (ATR, neat) 3027 cm−1; 1H NMR (400 MHz,
CDCl3): δ 7.33−7.23 (m, 2H), 7.22−7.13 (m, 3H), 5.40−5.27 (m,
1H), 3.35 (d, J = 7.4 Hz, 2H), 1.75 (d, J = 1.4 Hz, 3H), 1.72 (s, 3H);
13C{1H} NMR (101 MHz, CDCl3): δ 141.9, 132.6, 128.5, 128.4,
(S)-2,2,4,4-Tetramethyl-5-(3-methyl-6-phenylhex-3-en-1-yl)-1,3-
dioxolane [(S)-8b]. Following the general procedure for relay cross-
metathesis using acetonide (S)-(5d) (67 mg) and alkene 7a (200 mg)
gave trisubstituted alkene (S)-8b (51 mg, 0.17 mmol, 68%) as a light
brown oil and a mixture of E/Z geometrical isomers (E/Z = 70:30).
10.14469/hpc/6326. Rf 0.58 (5% EtOAc in petrol); IR (ATR, neat)
1
3023 cm−1; H NMR (400 MHz CDCl3): δ 7.32−7.24 (m, 2H),
7.23−7.15 (m, 3H), 5.29−5.20 (m, 1H), 3.66 (dd, J = 9.3, 3.5 Hz, E-
8b, 0.70H), 3.62 (dd, J = 9.6, 3.3 Hz, Z-8b, 0.30H), 2.70−2.61 (m,
2H), 2.38−2.27 (m, 2H), 2.27−2.10 (m, 1H), 2.09−1.96 (m, 1H),
1.74−1.68 (m, Z-8b, 0.90H), 1.67−1.59 (m, 1H), 1.58 (s, E-8b,
2.10H), 1.53−1.42 (m, 1H), 1.43 (s, E-8b, 2.10H), 1.43 (s, Z-8b,
0.90H), 1.33 (s, E-8b, 2.10H), 1.32 (s, Z-8b, 0.90H), 1.24 (s, E-8b,
2.10H), 1.23 (s, Z-8b, 0.90H), 1.11 (s, E-8b, 2.10H), 1.08 (s, Z-8b,
0.90H). The E/Z ratio was determined by integration of the
resonances at δ 1.11 (major) and 1.08 (minor) ppm; 13C{1H}
NMR (101 MHz, CDCl3): δ 142.3, 135.1, 128.5, 128.2, 125.7, 125.2,
124.1, 106.5, 82.8, 82.7, 80.1, 80.1, 36.7, 36.3, 36.1, 29.9, 29.8, 28.9,
28.6, 28.6, 27.8, 27.6, 26.9, 26.1, 23.3, 22.9, 16.0. The E-isomer was
identified as the major isomer on the basis of a characteristic shielded
methyl resonance23 at 16.0 versus 23.3 ppm for the minor Z-isomer;
HRMS (EI+) m/z: [M − CH3]+ calcd for C19H27O2, 287.2011; found,
287.2022. Data for (R)-8b was identical.
125.8, 123.3, 34.5, 25.9, 17.9; HRMS (EI+) m/z: [M]•+ calcd for
C11H14, 146.1090; found, 146.1084.
General Procedure for Preparation of Trisubstituted
Alkenes 8 via Relay Cross-Metathesis. To a neat mixture of
relay alkene 5 (0.25 mmol, 1.0 equiv) and alkene 7 (1.25 mmol, 5.0
equiv) was added ruthenium benzylidene 1 (21 mg, 0.025 mmol, 10
mol %). The mixture was heated to 50 °C using an oil bath for 1 h
under a strong positive pressure of N2 (g) via a needle in/out to aid
the removal of volatiles. The resulting mixture was loaded directly
onto a column of silica gel and chromatographed.
2,2-Dimethyl-3-(3-methyl-6-phenylhex-3-en-1-yl)oxirane (8a).2a
Following the general procedure for relay cross-metathesis using
epoxy allyl ether (E)-5a (53 mg) and alkene 7a (200 mg) gave
trisubstituted alkene 8a (51 mg, 0.21 mmol, 84% from (E)-5a; 42 mg,
0.17 mmol, 69% from (Z)-5a) as a colorless oil and a mixture of E/Z
geometrical isomers [E/Z = 73:27 (from (E)-5a) or 79:21 (from (Z)-
5a)]. 10.14469/hpc/5763. Rf 0.50 (10% EtOAc in pentanes); IR
3-(6-(4-Methoxyphenyl)-3-methylhex-3-en-1-yl)-2,2-dimethylox-
irane (8c).2a Following the general procedure for relay cross-
metathesis using epoxy allyl ether (E)- or (Z)-5a (53 mg) and
alkene 7c (250 mg, containing 5% p-methoxytoluene) gave
trisubstituted alkene 8c (45 mg, 0.17 mmol, 66% from (E)-5a; 41
mg, 0.16 mmol, 60% from (Z)-5a) as a brown oil and a mixture of E/
Z geometrical isomers [E/Z = 66:34 (from (E)-5a) or 67:33 (from
(Z)-5a)]. 10.14469/hpc/5817. Rf 0.35 (5% EtOAc in petrol); 1H
NMR (400 MHz, CDCl3): δ 7.10 (d, J = 8.6 Hz, 2H), 6.82 (d, J = 8.6,
2H), 5.25 (br t, J = 7.2 Hz, 1H), 3.79 (s, 3H), 2.72−2.66 (m, 1H),
2.63−2.54 (m, 2H), 2.34−2.23 (m, 2H), 2.21−2.04 (m, 2H), 1.70 (d,
J = 1.3 Hz, Z-8c, 1H), 1.60 (s, E-8c, 2H), 1.66−1.46 (m, 2H), 1.30 (s,
3H), 1.26 (s, E-8c, 2H), 1.25 (s, Z-8c, 1H); The E/Z ratio was
determined by integration of the resonances at δ 1.60 (major) and
1.70 (minor) ppm; 13C{1H} NMR (101 MHz, CDCl3): δ 157.8,
134.9, 134.9, 134.5, 129.4, 125.3, 124.4, 113.8, 113.8, 64.3, 64.2, 58.4,
55.4, 36.4, 35.5, 35.2, 30.3, 30.2, 28.6, 27.6, 27.5, 25.0, 25.0, 23.5,
1
(ATR, neat) 3026 cm−1; H NMR (400 MHz, CDCl3): δ 7.30−7.22
(m, 2H), 7.20−7.12 (m, 3H), 5.25−5.18 (m, 1H), 2.72−2.59 (m,
3H), 2.37−2.26 (m, 2H), 2.20−2.01 (m, 2H), 1.71−1.52 (m, 5H),
1.28 (s, 3H), 1.24 (s, E-8a, 2.19H), 1.24 (s, Z-8a, 0.81H). The E/Z
ratio was determined by integration of the resonances at δ 1.24(4)
(major) and 1.23(9) (minor) ppm; 13C{1H} NMR (101 MHz,
CDCl3): δ 142.4, 142.3, 135.0, 135.0, 128.6, 128.4, 128.4, 125.9,
125.9, 125.2, 124.4, 64.3, 64.2, 58.5, 58.5, 36.5, 36.4, 36.2, 30.1, 30.0,
28.7, 27.6, 27.5, 25.1, 25.1, 23.5, 18.9, 18.9, 16.1. The E-isomer was
identified as the major isomer on the basis of a characteristic shielded
methyl resonance23 at 16.1 versus 23.5 ppm for the minor Z-isomer;
HRMS (CI+) m/z: [M + H]+ calcd for C17H25O, 245.1905; found,
245.1900.
((E)-6-(((E)-3,7-Dimethylocta-2,6-dien-1-yl)oxy)hex-4-en-1-yl)-
benzene (9a) and 2,2-Dimethyl-3-((3E)-3-methyl-5-(prop-1-en-1-
H
J. Org. Chem. XXXX, XXX, XXX−XXX